Platform Specialty Products Corp. PAH 深 沪
已收盘 02-01 16:00:00 美东时间
11.24
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.24
- 总市值 34.14亿
- 52周最高 13.54
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.09
- 委 比 0.00%
- 总股本 3.04亿
- 历史最高 28.95
- 量 比 0
- 振 幅 0.00%
- 历史最低 5.25
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inhibikase Therapeutics To Initiate Phase 2b Study Of IKT-001 In PAH In H2 2025
-SEC Filing
08-15 05:06
Liquidia Analysts Raise Their Forecasts Following Q2 Results
Liquidia Corporation (NASDAQ:LQDA) reported a loss for the second quarter on Tu...
08-14 02:51
Liquidia Q2 2025 Earnings Preview
Liquidia (NASDAQ:LQDA) is scheduled to announce Q2 earnings results on Tuesday, August 12th, before market open. The consensus EPS Estimate is -$0.39 (-5.4% Y/Y) and the consensus Revenue Estimate is...
08-11 23:19
Keros Therapeutics Announces Strategic Realignment To Reallocate Resources Towards Development Of Its Key Clinical Program, KER-065; Discontinues Development of Cibotercept (KER-012)
Company Discontinuing Development of Cibotercept (KER-012)Announces Board and Leadership Changes Designed to Support Streamlined Operational Structureand Strategic RealignmentLEXINGTON, Mass., Aug. 06, 2025 (GLOBE
08-07 04:59
Century Complete Expands to Nevada With New Homes in Pahrump
National leader in online homebuying to begin selling at Ishani Ridge in August PAHRUMP, Nev., Aug. 5, 2025 /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS)—a top 10 national homebuilde...
08-06 02:10
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
NetworkNewsWire Editorial Coverage NEW YORK, Aug. 4, 2025 /PRNewswire/ -- As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that d...
08-04 20:30
United Therapeutics enters $1B accelerated share repurchase program
United Therapeutics (NASDAQ:UTHR) has entered into two accelerated share repurchase deal to buy back an aggregate of $1 billion of its common stock. The company will repurchase these shares as part of...
08-01 19:26
默沙东上半年营收下降2%，启动30亿美元成本节约计划
21世纪经济报道记者韩利明 7月29日，默沙东公布2025年上半年业绩报告显示，期内实现总营收313.35亿美元，同比下降2%；其中制药业务收入2...
07-30 14:47
Preview: United Therapeutics's Earnings
United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings ...
07-30 00:03
AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a favorable safety profile.
07-14 21:05
